- Home
- HE vs ENOV Comparison
HE vs ENOV Comparison
Compare HE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HE
- ENOV
- Stock Information
- Founded
- HE 1891
- ENOV 1995
- Country
- HE United States
- ENOV United States
- Employees
- HE N/A
- ENOV N/A
- Industry
- HE Electric Utilities: Central
- ENOV Fluid Controls
- Sector
- HE Utilities
- ENOV Industrials
- Exchange
- HE Nasdaq
- ENOV Nasdaq
- Market Cap
- HE 1.9B
- ENOV 1.8B
- IPO Year
- HE N/A
- ENOV 2008
- Fundamental
- Price
- HE $11.28
- ENOV $31.14
- Analyst Decision
- HE Hold
- ENOV Strong Buy
- Analyst Count
- HE 4
- ENOV 6
- Target Price
- HE $10.94
- ENOV $51.00
- AVG Volume (30 Days)
- HE 1.7M
- ENOV 646.7K
- Earning Date
- HE 11-07-2025
- ENOV 11-05-2025
- Dividend Yield
- HE N/A
- ENOV N/A
- EPS Growth
- HE N/A
- ENOV N/A
- EPS
- HE N/A
- ENOV N/A
- Revenue
- HE $3,122,881,000.00
- ENOV $2,189,576,000.00
- Revenue This Year
- HE $12.58
- ENOV $9.13
- Revenue Next Year
- HE $2.10
- ENOV $6.39
- P/E Ratio
- HE N/A
- ENOV N/A
- Revenue Growth
- HE 2.36
- ENOV 14.40
- 52 Week Low
- HE $8.14
- ENOV $25.47
- 52 Week High
- HE $13.41
- ENOV $49.83
- Technical
- Relative Strength Index (RSI)
- HE 47.65
- ENOV 51.28
- Support Level
- HE $10.79
- ENOV $29.00
- Resistance Level
- HE $11.46
- ENOV $32.01
- Average True Range (ATR)
- HE 0.23
- ENOV 1.23
- MACD
- HE 0.02
- ENOV -0.02
- Stochastic Oscillator
- HE 72.39
- ENOV 62.39
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.